Manufacturer copay assistance · Ultomiris (J1303) · Alexion (AstraZeneca Rare Disease)
Eligible patients pay as… · Maximum benefit Up to $15,000/year · Covers Ultomiris drug cost only — does NOT cover infusion administration
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Ultomiris — the program's cap applies against the patient share CareCost calculates.
Yes — Alexion OneSource Co-pay Program (Ultomiris) from Alexion (AstraZeneca Rare Disease). Eligible patients pay as little as $0 per prescription. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible patients pay as little as $0 per prescription Maximum benefit: Up to $15,000/year. Covers Ultomiris drug cost only — does NOT cover infusion administration
Accepted insurance: commercial. Not eligible: medicare, medicaid, tricare, va, government.